Triana Biomedicines

TRIANA Biomedicines is a venture capital-backed biopharmaceutical company leading a transformative approach to discovering and developing novel small molecules for the treatment of diseases. The company is developing molecular glue therapeutics, initially tailored for protein degradation applications. TRIANA is using a target-first, rational approach to discover molecular glues and is committed to developing products for a wide range of therapeutic applications.